The International Journal of Biological Markers

23.1k citations
1.8k papers · indexed · active since 1950

Impact in

    • Cancer-related molecular mechanisms research
    • Cancer Genomics and Diagnostics
  • Oncology top 5%
    • Peptidase Inhibition and Analysis
    • Cancer Cells and Metastasis
    • HER2/EGFR in Cancer Research

Papers in

    • Cancer Genomics and Diagnostics 92
    • HER2/EGFR in Cancer Research 121
    • Peptidase Inhibition and Analysis 96
    • Colorectal Cancer Treatments and Studies 92

The International Journal of Biological Markers

1.8k papers receiving 22.5k citations

Peers

The International Journal of Biological Markers
Comparison fields: 5 of 194
  • Cancer Research 5.8k
  • Oncology 8.7k
  • Molecular Biology 9.3k
  • Pulmonary and Respiratory Medicine 4.3k
  • Reproductive Medicine 1.1k
Replace Cancer treatment and research with:
Cancer treatment and research United States
Expert Review of Molecular Diagnostics United States
Recent results in cancer research Germany
Applied immunohistochemistry & molecular morphology United States
Diagnostic Pathology China
International Journal of Experimental Pathology United Kingdom
Archives of Medical Research Mexico
Cancer Biomarkers China
Pathobiology United States
Cancer Biotherapy and Radiopharmaceuticals China
The International Journal of Biological Markers relative to Cancer treatment and research United States Cancer treatment and research's profile →
Citations per field
00.5×1.5×
Cancer treatment and research · 1×
Citations per year

Countries where authors publish in The International Journal of Biological Markers

Since Specialization
Citations

This map shows the geographic impact of research published in The International Journal of Biological Markers. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in The International Journal of Biological Markers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The International Journal of Biological Markers more than expected).

Fields of papers published in The International Journal of Biological Markers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in The International Journal of Biological Markers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in The International Journal of Biological Markers.

About The International Journal of Biological Markers

The 1.8k papers published in The International Journal of Biological Markers in the last decades have received a total of 23.1k indexed citations . Papers published in The International Journal of Biological Markers usually cover Cancer Research (458 papers), Oncology (766 papers), Immunology and Allergy (73 papers), Pathology and Forensic Medicine (214 papers) and Pulmonary and Respiratory Medicine (387 papers) specifically the topics of Monoclonal and Polyclonal Antibodies Research (155 papers), Glycosylation and Glycoproteins Research (122 papers), Genetic factors in colorectal cancer (122 papers), HER2/EGFR in Cancer Research (121 papers), Peptidase Inhibition and Analysis (96 papers), Colorectal Cancer Treatments and Studies (92 papers), Prostate Cancer Treatment and Research (92 papers) and Cancer Genomics and Diagnostics (92 papers). The most active scholars publishing in The International Journal of Biological Markers are Jonas Cicenas, Ettore Marubini, Demetrios�� Spandidos, R. Moll, Paolo Verderio, E H Cooper, R. Artusi, Jung‐Soo Pyo, Nils Brünner and Massimo Gion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2026